LAPOINTE ANTHONY GREGG received a stock award from RIGEL PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/28/2025ACC: 0000905148-25-001933
Director
Since May 2019
+5.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
25.0%
5/23/2025
10K→12.50K
Total
Net shares
+2.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2025 | A · Award | +2.50K | — | — | 25.0% | 10K | 12.50K |
| Total | +2.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3K shares
Shares
+3K
Strike price
18.95
Held after
3K
Exercisable
—
5/23/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3K shares | 5/23/2025 | A · Award | +3K | 18.95 | — | 3K |